tiprankstipranks
Trending News
More News >

Daniel J. Becker Insider Profile

4 Followers
Daniel J. Becker, Director at Principia Biopharma, holds 0.00 shares in ACELYRIN, INC. (Ticker: SLRN), holds 5.00K shares in Day One Biopharmaceuticals (Ticker: DAWN), holds 0.00 shares in Pandion Therapeutics (Ticker: PAND).
tipranks
Daniel J. Becker

Daniel J. Becker
Principia Biopharma (PRNB)
Director

Ranked #21,132 out of 102,971 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+22.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$34K
100.00%
0.00%
A breakdown of Daniel J. Becker's holdings

Insider Roles

Day One Biopharmaceuticals
(DAWN)
Director
Zura Bio
(ZURA)
Director
Roles that Daniel J. Becker holds in companies

Most Profitable Insider Trade

Stock:
Principia Biopharma
(PRNB)
Rating:Informative Buy
Date:Oct 22, 2019 - Oct 22, 2020
Return:+222.40%
The most profitable trade made by Daniel J. Becker

Daniel J. Becker's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PRNB
Principia Biopharma
Sep 28, 2020
Uninformative Sell
66.76M
$0.00
PAND
Pandion Therapeutics
Apr 01, 2021
Uninformative Sell
169.73M
$0.00
Day One Biopharmaceuticals
Jun 01, 2021
Director
Informative Buy
80.00K
$33.75K
SLRN
ACELYRIN, INC.
May 23, 2025
Uninformative Sell
$0.00
Zura Bio
Director
List of latest transactions for each holding click on a transaction to see Daniel J. Becker's performance on stock

Daniel J. Becker insider profile FAQ

What is the percentage of profitable transactions made by Daniel J. Becker?
The percentage of profitable transactions made by Daniel J. Becker is 50%.
    What is the average return per transaction made by Daniel J. Becker?
    The average return per transaction made by Daniel J. Becker is 22.30%.
      What stocks does Daniel J. Becker hold?
      Daniel J. Becker holds: PRNB, PAND, DAWN, SLRN, ZURA stocks.
        What was Daniel J. Becker’s latest transaction?
        Daniel J. Becker latest transaction was an Uninformative Sell of ―.
          What was Daniel J. Becker's most profitable transaction?
          Daniel J. Becker’s most profitable transaction was an Informative Buy of PRNB stock on October 22, 2019. The return on the trade was 222.40%.
            What is Daniel J. Becker's role in Principia Biopharma?
            Daniel J. Becker's role in Principia Biopharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.